Press Room

Press Room

Press release

Duchesnay Inc. is seeking Health Canada's approval for ospemifene for the treatment of moderate to severe dyspareunia and vaginal dryness, symptoms of vulvar and vaginal atrophy (VVA), a component of genitourinary syndrome of menopause (GSM)

Read more >
Press release

Prevegyne®, the ONLY 6-day vaginal tablet treatment for non-specific vaginitis/bacterial vaginosis, now with the convenience of a vaginal applicator

Read more >
Press release

Duchesnay Donates $18,500 to Moisson Laurentides Food Bank

Read more >
Press release

Mictoryl® Pediatric (propiverine hydrochloride) now covered by several public drug plans to treat symptoms associated with overactive bladder

Read more >
Press release

Mictoryl® and Mictoryl® Pediatric now available and distributed in Canada by Duchesnay

Read more >